<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Wed, 01 Apr 2026 11:57:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  NT 10-K    WINDTREE THERAPEUTICS     For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++WINDTREE+THERAPEUTICS+++++For%3A+Dec+31/26257123.html</link>
   <description>si-local-file:///var/storage/secattach/20260401/26257123.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++WINDTREE+THERAPEUTICS+++++For%3A+Dec+31/26257123.html</guid>
   <pubDate>Wed, 01 Apr 2026 11:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Form  NT 10-K    WINDTREE THERAPEUTICS     For: Dec 31</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++WINDTREE+THERAPEUTICS+++++For%3A+Dec+31/26257123.html</link>
   <description>si-local-file:///var/storage/secattach/20260401/26257123.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++NT+10-K++++WINDTREE+THERAPEUTICS+++++For%3A+Dec+31/26257123.html</guid>
   <pubDate>Wed, 01 Apr 2026 11:57:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>CommLoan Achieves Nationwide Regulatory Approval Across All 50 States</title>
   <link>http://www.streetinsider.com/Press+Releases/CommLoan+Achieves+Nationwide+Regulatory+Approval+Across+All+50+States/26170816.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Company plans reverse merger with &lt;span value=&quot;OTC-PINK:WINT&quot; idsrc=&quot;xmltag.org&quot; &gt;Windtree Therapeutics&lt;/span&gt; as it expands its AI-powered commercial lending marketplace&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.az.scotsd&quot; idsrc=&quot;xmltag.org&quot; &gt;SCOTTSDALE, Ariz.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 17, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;u&gt;CommLoan&lt;/u&gt;, a commercial real estate lending technology company operating the first true AI-powered commercial mortgage lending marketplace, announced today that it has obtained the final approvals needed to operate and do business in all 50 states, without restriction.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
          </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CommLoan+Achieves+Nationwide+Regulatory+Approval+Across+All+50+States/26170816.html</guid>
   <pubDate>Tue, 17 Mar 2026 08:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>CommLoan Achieves Nationwide Regulatory Approval Across All 50 States</title>
   <link>http://www.streetinsider.com/Press+Releases/CommLoan+Achieves+Nationwide+Regulatory+Approval+Across+All+50+States/26170816.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Company plans reverse merger with &lt;span value=&quot;OTC-PINK:WINT&quot; idsrc=&quot;xmltag.org&quot; &gt;Windtree Therapeutics&lt;/span&gt; as it expands its AI-powered commercial lending marketplace&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.az.scotsd&quot; idsrc=&quot;xmltag.org&quot; &gt;SCOTTSDALE, Ariz.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 17, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;u&gt;CommLoan&lt;/u&gt;, a commercial real estate lending technology company operating the first true AI-powered commercial mortgage lending marketplace, announced today that it has obtained the final approvals needed to operate and do business in all 50 states, without restriction.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
          </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/CommLoan+Achieves+Nationwide+Regulatory+Approval+Across+All+50+States/26170816.html</guid>
   <pubDate>Tue, 17 Mar 2026 08:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>CommLoan Achieves Nationwide Regulatory Approval Across All 50 States</title>
   <link>http://www.streetinsider.com/PRNewswire/CommLoan+Achieves+Nationwide+Regulatory+Approval+Across+All+50+States/26170816.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Company plans reverse merger with &lt;span value=&quot;OTC-PINK:WINT&quot; idsrc=&quot;xmltag.org&quot; &gt;Windtree Therapeutics&lt;/span&gt; as it expands its AI-powered commercial lending marketplace&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.az.scotsd&quot; idsrc=&quot;xmltag.org&quot; &gt;SCOTTSDALE, Ariz.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 17, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;u&gt;CommLoan&lt;/u&gt;, a commercial real estate lending technology company operating the first true AI-powered commercial mortgage lending marketplace, announced today that it has obtained the final approvals needed to operate and do business in all 50 states, without restriction.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
          </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CommLoan+Achieves+Nationwide+Regulatory+Approval+Across+All+50+States/26170816.html</guid>
   <pubDate>Tue, 17 Mar 2026 08:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>CommLoan Achieves Nationwide Regulatory Approval Across All 50 States</title>
   <link>http://www.streetinsider.com/PRNewswire/CommLoan+Achieves+Nationwide+Regulatory+Approval+Across+All+50+States/26170816.html</link>
   <description>
&lt;div class=&quot;xn-content&quot;&gt;
&lt;p class=&quot;prntac&quot;&gt;&lt;i&gt;Company plans reverse merger with &lt;span value=&quot;OTC-PINK:WINT&quot; idsrc=&quot;xmltag.org&quot; &gt;Windtree Therapeutics&lt;/span&gt; as it expands its AI-powered commercial lending marketplace&lt;/i&gt;&lt;/p&gt;&lt;p&gt;&lt;span class=&quot;legendSpanClass&quot;&gt;&lt;location value=&quot;LU/us.az.scotsd&quot; idsrc=&quot;xmltag.org&quot; &gt;SCOTTSDALE, Ariz.&lt;/location&gt;&lt;/span&gt;, &lt;span class=&quot;legendSpanClass&quot;&gt;&lt;chron&gt;March 17, 2026&lt;/chron&gt;&lt;/span&gt; /PRNewswire/ -- &lt;u&gt;CommLoan&lt;/u&gt;, a commercial real estate lending technology company operating the first true AI-powered commercial mortgage lending marketplace, announced today that it has obtained the final approvals needed to operate and do business in all 50 states, without restriction.&lt;/p&gt;
    &lt;div class=&quot;PRN_ImbeddedAssetReference&quot; id=&quot;DivAssetPlaceHolder1&quot;&gt;
                &lt;p&gt;
          </description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/CommLoan+Achieves+Nationwide+Regulatory+Approval+Across+All+50+States/26170816.html</guid>
   <pubDate>Tue, 17 Mar 2026 08:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Form  8-K        WINDTREE THERAPEUTICS     For: Jan 05</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WINDTREE+THERAPEUTICS+++++For%3A+Jan+05/25820938.html</link>
   <description>si-local-file:///var/storage/secattach/20260107/25820938.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WINDTREE+THERAPEUTICS+++++For%3A+Jan+05/25820938.html</guid>
   <pubDate>Wed, 07 Jan 2026 16:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Form  8-K        WINDTREE THERAPEUTICS     For: Jan 05</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WINDTREE+THERAPEUTICS+++++For%3A+Jan+05/25820938.html</link>
   <description>si-local-file:///var/storage/secattach/20260107/25820938.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++WINDTREE+THERAPEUTICS+++++For%3A+Jan+05/25820938.html</guid>
   <pubDate>Wed, 07 Jan 2026 16:53:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates</title>
   <link>http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues)&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt; Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  23, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</guid>
   <pubDate>Tue, 23 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates</title>
   <link>http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues)&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt; Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  23, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</guid>
   <pubDate>Tue, 23 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates</title>
   <link>http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues)&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt; Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  23, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</guid>
   <pubDate>Tue, 23 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates</title>
   <link>http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues)&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt; Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  23, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</guid>
   <pubDate>Tue, 23 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues)&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt; Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  23, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</guid>
   <pubDate>Tue, 23 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues)&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt; Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  23, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</guid>
   <pubDate>Tue, 23 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues)&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt; Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  23, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</guid>
   <pubDate>Tue, 23 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces the Sale of its Cardiovascular Biotech Pipeline Drug Candidates</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Seismic Pharmaceutical Holdings, LLC acquires the cardiovascular assets and will pay Windtree 20% of any milestone payments, royalty payments or similar economic interests (including all global commercial net revenues)&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt; Windtree would receive a payment of $700,000 from Seismic Pharmaceutical Holdings contingent on a financing round resulting in gross cash proceeds of at least $10,000,000&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;Additionally, Windtree transfers certain cardiovascular development payables to Seismic Pharmaceutical Holdings&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  23, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Windtree+Therapeutics+Announces+the+Sale+of+its+Cardiovascular+Biotech+Pipeline+Drug+Candidates/25773728.html</guid>
   <pubDate>Tue, 23 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics signs letter of intent to acquire CommLoan</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Windtree+Therapeutics+signs+letter+of+intent+to+acquire+CommLoan/25693102.html</link>
   <description>

&lt;p&gt;Windtree Therapeutics, Inc. (OTCID: WINT) announced it has signed a letter of intent to acquire CommLoan, Inc., a commercial real estate lending technology company. The acquisition is part of Windtree's strategy to diversify into revenue-generating businesses.&lt;/p&gt;

&lt;p&gt;CommLoan will become a subsidiary of Windtree and retain key employees. Windtree has provided bridge financing to CommLoan during the transition period.&lt;/p&gt;

&lt;p&gt;CommLoan operates a commercial mortgage lending marketplace through its platform called CUPID, which connects borrowers and originators with lenders nationwide. The platform allows users to compare rates, terms, and loan structures across property types including multifamily, retail, office, industrial, healthcare, and SBA financing.&lt;/p&gt;

&lt;p&gt;&quot;We have</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Windtree+Therapeutics+signs+letter+of+intent+to+acquire+CommLoan/25693102.html</guid>
   <pubDate>Wed, 03 Dec 2025 09:00:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics signs letter of intent to acquire CommLoan</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Windtree+Therapeutics+signs+letter+of+intent+to+acquire+CommLoan/25693102.html</link>
   <description>

&lt;p&gt;Windtree Therapeutics, Inc. (OTCID: WINT) announced it has signed a letter of intent to acquire CommLoan, Inc., a commercial real estate lending technology company. The acquisition is part of Windtree's strategy to diversify into revenue-generating businesses.&lt;/p&gt;

&lt;p&gt;CommLoan will become a subsidiary of Windtree and retain key employees. Windtree has provided bridge financing to CommLoan during the transition period.&lt;/p&gt;

&lt;p&gt;CommLoan operates a commercial mortgage lending marketplace through its platform called CUPID, which connects borrowers and originators with lenders nationwide. The platform allows users to compare rates, terms, and loan structures across property types including multifamily, retail, office, industrial, healthcare, and SBA financing.&lt;/p&gt;

&lt;p&gt;&quot;We have</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Windtree+Therapeutics+signs+letter+of+intent+to+acquire+CommLoan/25693102.html</guid>
   <pubDate>Wed, 03 Dec 2025 09:00:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics signs letter of intent to acquire CommLoan</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Windtree+Therapeutics+signs+letter+of+intent+to+acquire+CommLoan/25693102.html</link>
   <description>

&lt;p&gt;Windtree Therapeutics, Inc. (OTCID: WINT) announced it has signed a letter of intent to acquire CommLoan, Inc., a commercial real estate lending technology company. The acquisition is part of Windtree's strategy to diversify into revenue-generating businesses.&lt;/p&gt;

&lt;p&gt;CommLoan will become a subsidiary of Windtree and retain key employees. Windtree has provided bridge financing to CommLoan during the transition period.&lt;/p&gt;

&lt;p&gt;CommLoan operates a commercial mortgage lending marketplace through its platform called CUPID, which connects borrowers and originators with lenders nationwide. The platform allows users to compare rates, terms, and loan structures across property types including multifamily, retail, office, industrial, healthcare, and SBA financing.&lt;/p&gt;

&lt;p&gt;&quot;We have</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Windtree+Therapeutics+signs+letter+of+intent+to+acquire+CommLoan/25693102.html</guid>
   <pubDate>Wed, 03 Dec 2025 09:00:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics signs letter of intent to acquire CommLoan</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Windtree+Therapeutics+signs+letter+of+intent+to+acquire+CommLoan/25693102.html</link>
   <description>

&lt;p&gt;Windtree Therapeutics, Inc. (OTCID: WINT) announced it has signed a letter of intent to acquire CommLoan, Inc., a commercial real estate lending technology company. The acquisition is part of Windtree's strategy to diversify into revenue-generating businesses.&lt;/p&gt;

&lt;p&gt;CommLoan will become a subsidiary of Windtree and retain key employees. Windtree has provided bridge financing to CommLoan during the transition period.&lt;/p&gt;

&lt;p&gt;CommLoan operates a commercial mortgage lending marketplace through its platform called CUPID, which connects borrowers and originators with lenders nationwide. The platform allows users to compare rates, terms, and loan structures across property types including multifamily, retail, office, industrial, healthcare, and SBA financing.&lt;/p&gt;

&lt;p&gt;&quot;We have</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Windtree+Therapeutics+signs+letter+of+intent+to+acquire+CommLoan/25693102.html</guid>
   <pubDate>Wed, 03 Dec 2025 09:00:28 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space</title>
   <link>http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+It+Has+Signed+a+Letter+of+Intent+to+Acquire+CommLoan%2C+Inc.+a+Revenue+Generating+Company+in+the+Rapidly+Growing+Fintech+Space/25693066.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;CommLoan has streamlined the process of obtaining commercial real estate financing&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  03, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent to acquire CommLoan, Inc., a commercial tech finance company.&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+It+Has+Signed+a+Letter+of+Intent+to+Acquire+CommLoan%2C+Inc.+a+Revenue+Generating+Company+in+the+Rapidly+Growing+Fintech+Space/25693066.html</guid>
   <pubDate>Wed, 03 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space</title>
   <link>http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+It+Has+Signed+a+Letter+of+Intent+to+Acquire+CommLoan%2C+Inc.+a+Revenue+Generating+Company+in+the+Rapidly+Growing+Fintech+Space/25693066.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;CommLoan has streamlined the process of obtaining commercial real estate financing&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  03, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent to acquire CommLoan, Inc., a commercial tech finance company.&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+It+Has+Signed+a+Letter+of+Intent+to+Acquire+CommLoan%2C+Inc.+a+Revenue+Generating+Company+in+the+Rapidly+Growing+Fintech+Space/25693066.html</guid>
   <pubDate>Wed, 03 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space</title>
   <link>http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+It+Has+Signed+a+Letter+of+Intent+to+Acquire+CommLoan%2C+Inc.+a+Revenue+Generating+Company+in+the+Rapidly+Growing+Fintech+Space/25693066.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;CommLoan has streamlined the process of obtaining commercial real estate financing&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  03, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent to acquire CommLoan, Inc., a commercial tech finance company.&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+It+Has+Signed+a+Letter+of+Intent+to+Acquire+CommLoan%2C+Inc.+a+Revenue+Generating+Company+in+the+Rapidly+Growing+Fintech+Space/25693066.html</guid>
   <pubDate>Wed, 03 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space</title>
   <link>http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+It+Has+Signed+a+Letter+of+Intent+to+Acquire+CommLoan%2C+Inc.+a+Revenue+Generating+Company+in+the+Rapidly+Growing+Fintech+Space/25693066.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;CommLoan has streamlined the process of obtaining commercial real estate financing&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  03, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent to acquire CommLoan, Inc., a commercial tech finance company.&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Windtree+Therapeutics+Announces+It+Has+Signed+a+Letter+of+Intent+to+Acquire+CommLoan%2C+Inc.+a+Revenue+Generating+Company+in+the+Rapidly+Growing+Fintech+Space/25693066.html</guid>
   <pubDate>Wed, 03 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
  <item>
   <title>Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire CommLoan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Windtree+Therapeutics+Announces+It+Has+Signed+a+Letter+of+Intent+to+Acquire+CommLoan%2C+Inc.+a+Revenue+Generating+Company+in+the+Rapidly+Growing+Fintech+Space/25693066.html</link>
   <description>
&lt;p align=&quot;center&quot;&gt;&lt;em&gt;Windtree is executing its corporate strategy to diversify its business with revenue and profit generating divisions&lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;CommLoan, Inc. is a tech company focused on transforming the way middle market loans are originated &lt;/em&gt;&lt;/p&gt;  &lt;p align=&quot;center&quot;&gt;&lt;em&gt;CommLoan has streamlined the process of obtaining commercial real estate financing&lt;/em&gt;&lt;/p&gt;  &lt;p&gt;WARRINGTON, Pa., Dec.  03, 2025  (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (OTCID: WINT), a diversified company with several divisions and focused on becoming a revenue generating company, announced that it has signed a letter of intent to acquire CommLoan, Inc., a commercial tech finance company.&lt;/p&gt; </description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Windtree+Therapeutics+Announces+It+Has+Signed+a+Letter+of+Intent+to+Acquire+CommLoan%2C+Inc.+a+Revenue+Generating+Company+in+the+Rapidly+Growing+Fintech+Space/25693066.html</guid>
   <pubDate>Wed, 03 Dec 2025 09:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.09642568</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00085080</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.20371933</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WINT</category>
   	  </item>
 </channel>
</rss>
